Associated Papers
Pan-Cancer Exome-wide analysis of germline mutational patterns and pathways.
Alnaqbi H et al.
Scientific Reports, 2025
40594066 (PubMed )
Supplement: 41598_2025_5296_MOESM2_ESM.xlsx › Supplementary_Table_1
Alternative splicing generates isoform diversity in MEN1.
Ramachandran A et al.
Endocrine Oncology (bristol, England), 2024
39649118 (PubMed )
Supplement: supplementary_table_3.xlsx › Supplementary_Table_3
Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.
Andersen KØ et al.
Frontiers in Endocrinology, 2024
38868744 (PubMed )
Supplement: DataSheet_1.docx
Multiple endocrine neoplasia type 1: a new germline "homozygous" variant (c.201delC) caused by detection errors.
Zhang F et al.
Hereditary Cancer in Clinical Practice, 2022
Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing.
Zheng K et al.
Experimental and Therapeutic Medicine, 2021
33747156 (PubMed )
Supplement: Supplementary_Data3.xlsx › Table_SII
Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing.
Carvalho RA et al.
European Journal of Endocrinology, 2018
Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile.
Lourenço DM et al.
European Journal of Endocrinology, 2008
Select a paper to view details